Application of Breast-Conserving Therapy in Breast Cancer Treatment

张涛,张保宁,余子豪,李晔雄,徐兵河

DOI: https://doi.org/10.3969/j.issn.1007-3639.2004.06.018

2004-01-01

Abstract:Purpose:To study the effect of breast-conser ving therapy for patients with stage Ⅰ and Ⅱ breast cancer. Methods:From March, 1990 to March, 2004, we performed breast-c onserving therapy for a selected group of patients with tumors less than or equa l to 3 cm and tumor-areola distance more than or equal to 2 cm. Some patients w ith tumors more than 3 cm accepted neoadjuvant chemotherapy and breast-conservi ng therapy was performed after the tumor became smaller. The tumor was excised w ith a normal tissue margin of 2 cm. Axillary dissection included level Ⅰ and Ⅱ . At beginning we performed one excision, then two excision later. After operati on, patients accepted radiotherapy first, then chemotherapy and (or) hormonother apy. Results:In 265 cases, the number of lymph nodes excised was 5- 29, and the average was 16. The local recurrences were all in the breast, and no axillary failure occurred. The 3-year, 5-year, 10-year overall survival rate s were 99%,94%,80% respectively, local recurrence rates were 5.4%,7%,7.7% re spectively, breast-conserving rates were 97.8%,93%,88% respectively. The cosm etic satisfactory rate of the breast was 83.2%. Conclusions:Breast-comserving therapy is recognized as a suita ble treatment for patients with stage Ⅰ and Ⅱ breast cancer, who can achieve a cceptable overall survival rates, local control rates and good cosmetic results. It is the preferential treatment for patients with breast cancer.